Vaxneuvance

Pneumococcal polysaccharide conjugate vaccine 15-valent (adsorbed)

Adult ≥18 yr: Active immunization for the prevention of invasive disease & pneumonia caused by Strep pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F & 33F. Infant 6 wk to 17 yr: Active immunization for the prevention of invasive disease, pneumonia & acute otitis media caused by Strep pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F & 33F.

IM 0.5 mL (1 dose). Adult Single dose. Unvaccinated or completed dosing regimen w/ lower-valency pneumococcal conjugate vaccines Childn & adolescent 2 - 17 yr Single dose. Childn 12-23 mth 2 doses w/ an interval of 2 mth between doses. Infant 7-11 mth 3 doses w/ the 1st 2 doses given at least 4 wk apart, followed by a 3rd dose given after 12 mth of age separated from 2nd dose by at least 2 mth. Previous pneumococcal conjugate vaccine was administered 2 mth should elapse before receiving another pneumococcal conjugate vaccine. Ped Routine vaccination schedule for infants & toddlers Infant 6-12 wk 3-dose regimen: Primary 2 dose series followed by a toddler dose consists of 3 doses w/ 1st dose given as early as 6-12 wk, administer a 2nd dose 8 wk later, followed by a 3rd dose to be administered approx 11-15 mth of age. 4-dose regimen: Primary 3 dose series followed by a toddler dose consists of 4 doses w/ 1st dose given as early as 6-12 wk w/ interval of 4-8 wk between doses in the primary series, followed by a 4th dose to be administered approx 11-15 mth of age & at least 2 mth after the 3rd dose. Pre-term infant <37 wk gestation Primary 3 dose series followed by a toddler dose consists of 4 doses w/ 1st dose given as early as 6-12 wk w/ interval of 4-8 wk between doses in the primary series, followed by a 4th dose to be administered approx 11-15 mth of age & at least 2 mth after the 3rd dose.

History of severe allergic reaction to any component of pneumococcal polysaccharide conjugate vaccine or to diphtheria toxoid.

Patients w/ altered immunocompetence, including those receiving immunosuppressive therapy. Pregnancy & lactation. Premature infant (potential risk of apnea w/ IM vaccine). Childn <6 wk.

Irritability, elevated body temp, somnolence, erythema, pain, decreased appetite, induration, swelling, urticaria.

May reduce immune response to vaccines w/ immunosuppressive therapies, including irradiation, antimetabolites, alkylating agents, cytotoxic drugs, corticosteroids, therapeutic proteins & targeted immunomodulators.

Vaccines, Antisera & Immunologicals

J07AL02 - pneumococcus, purified polysaccharides antigen conjugated ; Belongs to the class of pneumococcal bacterial vaccines.

Rx